Year: 2025

Researchers at WashU Medicine have found a way to target the vessels that drain waste from the brain. Rejuvenating those vessels could open the door to new therapies to prevent cognitive decline.

A multidisciplinary team led by WashU chemists repurposed an antimalarial drug in the fight against antibiotic resistance.

WashU rises in the National Academy of Inventors’ annual global ranking of patent awards.

A clinical trial among people destined to develop early-onset Alzheimer’s disease and led by WashU Medicine researchers shows eliminating amyloid from the brain may prevent cognitive symptoms.

WashU’s Doctoral Council seeks two new PhD students to serve for a two-year term beginning in August. The nomination deadline is April 11.

“¿Te puedo contar algo?”, an evening-length concert featuring new and original works by MFA candidates Tess Angelica Losada-Tindall and Lourdes del Mar Santiago Lebrón in Arts & Sciences, will explore the nature, power and necessity of grief March 21 and 22 in WashU’s Edison Theatre.

Jessica Backman-Levy (left), at the Brown School, and Beryne Odeny, MD, PhD, at the School of Medicine, have been selected to participate in a yearlong program aimed at advancing women into senior leadership positions in global health.

The Jansky/Bander Family Fund, a generous commitment of $1.1 million over five years, has been established to advance critical initiatives within the Section of Movement Disorders in the Department of Neurology at WashU Medicine.

The ad hoc committee established by the WashU Board of Trustees to review the university’s policies and guidelines governing on-campus protests and demonstrations has completed its work.

Wilmetta Toliver-Diallo never stops her work on behalf of students. When she is not helping students apply for competitive fellowships, she is lecturing in the Department of African and African American Studies. And when she is not mentoring Mellon Mays fellows, she’s co-hosting dinners for her neighbors on the South 40.